Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Profit After Tax

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,883 Cr₹1,388 Cr₹715 Cr₹170 Cr₹442 Cr

What is the latest Profit After Tax of NATCO PHARMA ?

The latest Profit After Tax ratio of NATCO PHARMA is ₹1,883 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,883 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹442 Cr

How is Profit After Tax of NATCO PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,883 Cr
35.66
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.57
Mar2021 ₹442 Cr -

Compare Profit After Tax of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,194.8 Cr -0.6% -5.7% -45.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,167.0 Cr NA -0.9% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-0.6%

-5.7%

-45.3%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses